Key result
Contemporary cardiac sarcoidosis prognosis improves overall, but baseline heart failure still carries poor long-term outcomes.
Why the study?
The detection rate of cardiac sarcoidosis has increased markedly in Finland over 25 years, but prognosis and outcomes vary, especially in heart failure patients.
While the detection of cardiac sarcoidosis has increased and overall prognosis has improved with current therapy, patients presenting with heart failure continue to have poor long-term outcomes.
Rising CS detection and better overall prognosis may inform screening; leaves open HF-specific management strategies.
The detection rate of CS has increased markedly in Finland over the last 25 years. With current therapy, the prognosis of CS appears better than generally considered, but patients presenting with heart failure still have poor long-term outcome.
No takes yet. Share an insight, caveat, or question.
Kandolin et al. (2014) studied this question. Cardiac sarcoidosis treated with current therapy has a better overall prognosis than generally considered, but patients presenting with heart failure still have poor long-term outcomes.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: